American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

Source: David S. Boyer, MD
November 24, 2021
1 min watch
Save

VIDEO: EYP-1901 found to be ‘extremely safe,’ efficacious in first results

Source: David S. Boyer, MD
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, David S. Boyer, MD, discusses 6-month results of the DAVIO trial, investigating EYP-1901 (EyePoint Pharmaceuticals) in patients with wet AMD.